4303 related articles for article (PubMed ID: 15598916)
21. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
22. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
Schmieder RE; Martus P; Klingbeil A
JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular outcomes and antihypertensive drug treatment in older women.
Staessen JA; Thijs L; Wang J; Li Y
JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811972
[No Abstract] [Full Text] [Related]
24. Cardiovascular outcomes and antihypertensive drug treatment in older women.
Bursztyn M
JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811971
[No Abstract] [Full Text] [Related]
25. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
26. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
27. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
28. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis.
Palmas W; Ma S; Psaty B; Goff DC; Darwin C; Barr RG
Am J Hypertens; 2007 Mar; 20(3):233-41. PubMed ID: 17324732
[TBL] [Abstract][Full Text] [Related]
30. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
Psaty BM; Smith NL; Siscovick DS; Koepsell TD; Weiss NS; Heckbert SR; Lemaitre RN; Wagner EH; Furberg CD
JAMA; 1997 Mar; 277(9):739-45. PubMed ID: 9042847
[TBL] [Abstract][Full Text] [Related]
31. Drug therapy for hypertension in the elderly.
Kligman EW; Higbee MD
J Fam Pract; 1989 Jan; 28(1):81-7. PubMed ID: 2563274
[TBL] [Abstract][Full Text] [Related]
32. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
Reboldi G; Gentile G; Angeli F; Verdecchia P
Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778
[TBL] [Abstract][Full Text] [Related]
33. Novel combinations in the treatment of hypertension.
Sica DA
Minerva Urol Nefrol; 2005 Sep; 57(3):129-39. PubMed ID: 15986012
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
[TBL] [Abstract][Full Text] [Related]
35. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
36. Prescribing pattern of antihypertensive drugs by family physicians and general practitioners in the primary care setting in Bahrain.
Sequeira RP; Jassim KA; Damanhori AH; Mathur VS
J Eval Clin Pract; 2002 Nov; 8(4):407-14. PubMed ID: 12421390
[TBL] [Abstract][Full Text] [Related]
37. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell'Anziano.
Crucitti A; Cecchi E; Gensini GF; Simone I; Conti A; Gialloni S; Pedone C; Pahor M; Mugelli A
Pharmacol Res; 2000 Feb; 41(2):249-53. PubMed ID: 10623493
[TBL] [Abstract][Full Text] [Related]
38. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
39. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
40. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
Turnbull F;
Lancet; 2003 Nov; 362(9395):1527-35. PubMed ID: 14615107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]